TVGNW
Tevogen Bio Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.05
−8.91%Next report
Analyst consensus
- Next report date
- Nov 24, 2026
- EPS estimate
- -$2.56
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$1.52
- EPS estimate
- -$2.54
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +32.8%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$2.54 | -$1.52 | Beat 40.04% | — |
| May 15, 2026 | -$2.64 | -$1.61 | Beat 39.02% | — |
| Feb 25, 2026 | -$0.03 | -$0.03 | In line | — |
| Nov 14, 2025 | -$0.06 | -$0.03 | Beat 51.96% | — |
| Aug 14, 2025 | -$0.05 | -$0.03 | Beat 40.28% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 24, 2026